Literature DB >> 2522580

Effect of moxisylyte hydrochloride on isolated human penile corpus cavernosum tissue.

A Imagawa1, K Kimura, Y Kawanishi, M Tamura.   

Abstract

The effect of moxisylyte hydrochloride on isolated human penile corpus cavernosum tissue was investigated and compared with other a-adrenergic antagonists. Moxisylyte produced a concentration-dependent relaxation of a norepinephrine-induced (1 x 10(-5) M) contraction of the corpus cavernosum tissue. Pretreatment with 1 x 10(-6) M doses of moxisylyte reduced competitively the norepinephrine-induced contraction. The competitive effect of prazosin was strongest among four tested agents, followed by phentolamine, moxisylyte, and then yohimbine. The activity ratio for each antagonist is 2.4 for moxisylyte, as compared with 28.2 for prazosin, 6.7 for phentolamine, and 1.6 for yohimbine respectively. Moxisylyte hydrochloride is an agent with potential clinical and research uses capable of producing erection when injected intra-cavernously.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2522580     DOI: 10.1016/0024-3205(89)90194-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

Review 1.  Drugs for the treatment of impotence.

Authors:  L Garcia-Reboll; J P Mulhall; I Goldstein
Journal:  Drugs Aging       Date:  1997-08       Impact factor: 3.923

Review 2.  Intracavernous pharmacotherapy.

Authors:  M C Truss; A J Becker; D Schultheiss; U Jonas
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 3.  Pharmacological management of erectile dysfunction.

Authors:  F Montorsi; G Guazzoni; P Rigatti; G Pozza
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

Review 4.  Erectile dysfunction: expectations beyond phosphodiesterase type 5 inhibition.

Authors:  A Aversa; M Pili; A Fabbri; E Spera; G Spera
Journal:  J Endocrinol Invest       Date:  2004-02       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.